LeaderPortfolio
Therapeutics
healthcare British biotechnology0

Summit Therapeutics

Market Cap
$17B
Stock Price
$19.46
SMMT
Summit Therapeutics
Revenue--
Employees130

Corporate Profile

Summit Therapeutics stands as a titan in the healthcare sector. With a valuation of $17 Billion, the company employs over 130 people worldwide. Headquartered in British biotechnology, it continues to drive innovation and maintain its market dominance.

Financial Performance

Revenue
--
Market Cap
$17B
Stock
$19.46